ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION




On January 13, 2021, in advance of a public webcast presentation at the J.P.
Morgan Healthcare Conference on the same date, Danaher Corporation issued a
press release regarding the Company's anticipated financial performance for the
fourth quarter of 2020 and furnished pursuant to Item 2.02 of Form 8-K such
press release as well as the presentation slides attached hereto, each of which
is incorporated by reference herein. The presentation slides attached hereto
contain certain information regarding Danaher's anticipated financial
performance for 2020.
This information shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), or
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as shall be expressly set forth by specific
reference in such a filing.


ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS



              (c) Exhibits:

   Exhibit No.                         Description

      99.1                               Press release - "Danaher CEO to

Comment on Financial Performance"


     99.1PRE                             Selected Danaher Presentation 

Slides for J.P. Morgan Healthcare


                                       Conference on January 13, 2021
       104                             Cover Page Interactive Data File 

(formatted as inline XBRL with applicable


                                       taxonomy extension information contained in Exhibits 101)



--------------------------------------------------------------------------------

© Edgar Online, source Glimpses